- Zacks•13 hours ago
Intelligent care is where modern medicine seems to be headed with pharma and tech companies collaborating for better healthcare solutions.
- Zacks•14 hours ago
Glaxo (GSK) and Janssen Biologics announced the submission of a BLA for sirukumab for the treatment of adults with moderate-to-severely active RA in the U.S.
GlaxoSmithKline plc (GSK.L)
LSE - LSE Delayed Price. Currency in GBp
|Bid||1,631.00 x 175400|
|Ask||1,650.00 x 417900|
|Day's Range||1,633.50 - 1,649.00|
|52wk Range||1,227.50 - 1,716.50|
|1y Target Est||N/A|
|P/E Ratio (ttm)||2,722.50|
|Avg Vol (3m)||8,270,830|
|Dividend & Yield||N/A (N/A)|